BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Reality TV star Spencer Pratt, who lost his home in Palisades Fire, is running for mayor of Los Angeles - 2The Significance of Health Projects in Senior Protection.
- 3Scientists document a death from a meat allergy tied to certain ticks
- 4South Africa collects record $117B tax haul
- 5Your big brain makes you human – count your neurons when you count your blessings
- Doctors say changes to US vaccine recommendations are confusing parents and could harm kids
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- Astrophotographer captures spectacular photo of Antennae Galaxies dueling in deep space
- A Russian fighting for Ukraine conned the Kremlin out of $500,000 by faking his own death
- Obamacare enrollment declines as US subsidies expire
- A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
- Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
- Space debris: will it take a catastrophe for nations to take the issue seriously?
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
